Gupta S, Silveira D, Mombach J, Hashimoto R
Proteomes. 2025; 13(1.
PMID: 39846637
PMC: 11755436.
DOI: 10.3390/proteomes13010006.
Dabour M, Abdelgawad I, Sadaf B, Daniel M, Grant M, Seelig D
Biomed Pharmacother. 2024; 179:117288.
PMID: 39146767
PMC: 11447837.
DOI: 10.1016/j.biopha.2024.117288.
Patil M, Singh S, Dubey P, Tousif S, Umbarkar P, Zhang Q
JACC Basic Transl Sci. 2024; 9(6):754-770.
PMID: 39070272
PMC: 11282885.
DOI: 10.1016/j.jacbts.2024.03.004.
Wehbe N, Badran A, Baydoun S, Al-Sawalmih A, Maresca M, Baydoun E
Antioxidants (Basel). 2024; 13(6).
PMID: 38929164
PMC: 11200955.
DOI: 10.3390/antiox13060726.
Lachiondo-Ortega S, Rejano-Gordillo C, Simon J, Lopitz-Otsoa F, C Delgado T, Mazan-Mamczarz K
Cell Rep. 2024; 43(3):113924.
PMID: 38507413
PMC: 11025316.
DOI: 10.1016/j.celrep.2024.113924.
Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-κB and MAPKs: implications in vascular diseases.
Zhou H, Khan D, Hussain S, Gerdes N, Hagenbeck C, Rana M
J Inflamm (Lond). 2023; 20(1):41.
PMID: 38001470
PMC: 10675905.
DOI: 10.1186/s12950-023-00366-7.
A novel small molecule inhibitor of p38⍺ MAP kinase augments cardiomyocyte cell cycle entry in response to direct cell cycle stimulation.
Abouleisa R, Miller J, Gebreil A, Salama A, Dwenger M, Abdelhafez H
Br J Pharmacol. 2023; 180(24):3271-3289.
PMID: 37547998
PMC: 10726296.
DOI: 10.1111/bph.16209.
Hepatitis C virus non-structural proteins modulate cellular kinases for increased cytoplasmic abundance of host factor HuR and facilitate viral replication.
Raheja H, George B, Tripathi S, Saha S, Maiti T, Das S
PLoS Pathog. 2023; 19(8):e1011552.
PMID: 37540723
PMC: 10431626.
DOI: 10.1371/journal.ppat.1011552.
Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells.
Liu Z, Krstic A, Neve A, Casalou C, Rauch N, Wynne K
Int J Mol Sci. 2023; 24(14).
PMID: 37511580
PMC: 10380721.
DOI: 10.3390/ijms241411821.
MAPK11 (p38β) is a major determinant of cellular radiosensitivity by controlling ionizing radiation-associated senescence: An in vitro study.
Fernandez-Aroca D, Garcia-Flores N, Frost S, Jimenez-Suarez J, Rodriguez-Gonzalez A, Fernandez-Aroca P
Clin Transl Radiat Oncol. 2023; 41:100649.
PMID: 37346275
PMC: 10279794.
DOI: 10.1016/j.ctro.2023.100649.
Colchicine Protects against Ethanol-Induced Senescence and Senescence-Associated Secretory Phenotype in Endothelial Cells.
Zhou H, Khan D, Gerdes N, Hagenbeck C, Rana M, Cornelius J
Antioxidants (Basel). 2023; 12(4).
PMID: 37107335
PMC: 10135532.
DOI: 10.3390/antiox12040960.
Biomarkers of aging.
Bao H, Cao J, Chen M, Chen M, Chen W, Chen X
Sci China Life Sci. 2023; 66(5):893-1066.
PMID: 37076725
PMC: 10115486.
DOI: 10.1007/s11427-023-2305-0.
An AKT1-and TRIM21-mediated phosphodegron controls proteasomal degradation of HuR enabling cell survival under heat shock.
Nag S, Rahaman S, Guha A, Ray P
iScience. 2023; 26(4):106307.
PMID: 36968077
PMC: 10034463.
DOI: 10.1016/j.isci.2023.106307.
Role of ubiquitin regulatory X domain‑containing protein 3B in the development of hepatocellular carcinoma (Review).
Guo Z, Liang J
Oncol Rep. 2023; 49(3).
PMID: 36799187
PMC: 9942258.
DOI: 10.3892/or.2023.8494.
P38 MAPK and Radiotherapy: Foes or Friends?.
Garcia-Flores N, Jimenez-Suarez J, Garnes-Garcia C, Fernandez-Aroca D, Sabater S, Andres I
Cancers (Basel). 2023; 15(3).
PMID: 36765819
PMC: 9913882.
DOI: 10.3390/cancers15030861.
Anastasis confers ovarian cancer cells increased malignancy through elevated p38 MAPK activation.
Sun L, Yao C, Li X, Wang Y, Wang R, Wang M
Cell Death Differ. 2022; 30(3):809-824.
PMID: 36447048
PMC: 9984481.
DOI: 10.1038/s41418-022-01081-1.
Ethanolic extract of leaves exhibits potent anti-breast cancer potential and robust antioxidant properties.
Mesmar J, Abdallah R, Hamade K, Baydoun S, Al-Thani N, Shaito A
Front Pharmacol. 2022; 13:994025.
PMID: 36299882
PMC: 9589507.
DOI: 10.3389/fphar.2022.994025.
RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer.
Mehta M, Raguraman R, Ramesh R, Munshi A
Adv Drug Deliv Rev. 2022; 191:114569.
PMID: 36252617
PMC: 10411638.
DOI: 10.1016/j.addr.2022.114569.
HuR as a molecular target for cancer therapeutics and immune-related disorders.
Majumder M, Chakraborty P, Mohan S, Mehrotra S, Palanisamy V
Adv Drug Deliv Rev. 2022; 188:114442.
PMID: 35817212
PMC: 10276344.
DOI: 10.1016/j.addr.2022.114442.
Hu Antigen R (HuR) Protein Structure, Function and Regulation in Hepatobiliary Tumors.
Lachiondo-Ortega S, Cardoso Delgado T, Banos-Jaime B, Velazquez-Cruz A, Diaz-Moreno I, Martinez-Chantar M
Cancers (Basel). 2022; 14(11).
PMID: 35681645
PMC: 9179498.
DOI: 10.3390/cancers14112666.